| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.24 | 9e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |